Optiver Holding B.V. Innate Pharma Sa Call Options Transaction History
Optiver Holding B.V.
- $2.38 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding IPHA
# of Institutions
10Shares Held
254KCall Options Held
0Put Options Held
0-
Exchange Traded Concepts, LLC113KShares$243,1000.01% of portfolio
-
Morgan Stanley New York, NY44.1KShares$94,8660.0% of portfolio
-
Jane Street Group, LLC New York, NY14.6KShares$31,2910.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny10.6KShares$22,7440.0% of portfolio
-
Barclays PLC London, X0412Shares$8850.0% of portfolio
About Innate Pharma SA
- Ticker IPHA
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 79,893,000
- Market Cap $172M
- Description
- Innate Pharma S.A., a biotechnology company, discovers, develops, and commercializes therapeutic antibodies for the treatment of oncology indications in France and internationally. The company's products include Lacutamab (IPH4102), an anti-KIR3DL2 antibody, which is in Phase II clinical trials for the treatment of cutaneous T-cell and periphera...